On Tuesday, Integra Lifesciences Holdings Corp (NASDAQ: IART) opened lower -3.56% from the last session, before settling in for the closing price of $24.18. Price fluctuations for IART have ranged from $16.81 to $45.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 0.70% over the past five years. Company’s average yearly earnings per share was noted -20.92% at the time writing. With a float of $66.02 million, this company’s outstanding shares have now reached $77.13 million.
Let’s look at the performance matrix of the company that is accounted for 5329 employees. In terms of profitability, gross margin is 55.82%, operating margin of 5.56%, and the pretax margin is -0.76%.
Integra Lifesciences Holdings Corp (IART) Insider Updates
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Integra Lifesciences Holdings Corp is 14.44%, while institutional ownership is 89.36%. The most recent insider transaction that took place on Dec 03 ’24, was worth 100,102. In this transaction EVP, Chief Legal Officer & Sec of this company sold 4,070 shares at a rate of $24.59, taking the stock ownership to the 59,511 shares. Before that another transaction happened on Dec 03 ’24, when Company’s Officer proposed sale 4,070 for $24.59, making the entire transaction worth $100,102.
Integra Lifesciences Holdings Corp (IART) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -20.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.57% during the next five years compared to 3.10% growth over the previous five years of trading.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Check out the current performance indicators for Integra Lifesciences Holdings Corp (IART). In the past quarter, the stock posted a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.15. Likewise, its price to free cash flow for the trailing twelve months is 47.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit 0.85 in the next quarter and is forecasted to reach 2.51 in one year’s time.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Integra Lifesciences Holdings Corp (NASDAQ: IART) saw its 5-day average volume 0.45 million, a negative change from its year-to-date volume of 0.54 million. As of the previous 9 days, the stock’s Stochastic %D was 10.90%. Additionally, its Average True Range was 0.88.
During the past 100 days, Integra Lifesciences Holdings Corp’s (IART) raw stochastic average was set at 63.10%, which indicates a significant increase from 1.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.67% in the past 14 days, which was lower than the 52.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.94, while its 200-day Moving Average is $24.04. Nevertheless, the first resistance level for the watch stands at $23.93 in the near term. At $24.54, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.88. If the price goes on to break the first support level at $22.98, it is likely to go to the next support level at $22.64. Assuming the price breaks the second support level, the third support level stands at $22.03.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Key Stats
There are currently 77,164K shares outstanding in the company with a market cap of 1.80 billion. Presently, the company’s annual sales total 1,542 M according to its annual income of 67,740 K. Last quarter, the company’s sales amounted to 380,830 K and its income totaled -10,700 K.
